Breast Atypical Lobular Hyperplasia
5 clinical trials · Condition
◉ Watch Breast Atypical Lobular Hyperplasia
| Record | Firm | Date |
|---|---|---|
| Oral Tamoxifen vs. TamGel vs. Control in Women With Atypical Hyperplasia, Lobular Carcinoma In Situ, or Increased Breast Cancer Risk (NCT04570956) | Mayo Clinic | 2021-07-26 |
| Bexarotene in Preventing Breast Cancer in Patients at High Risk for Breast Cancer (NCT03323658) | National Cancer Institute (NCI) | 2018-06-15 |
Track Breast Atypical Lobular Hyperplasia automatically
Every clearance here is in the API, with alerts when new ones post.